Clinical Trial Update: Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway

View source ↗

Summary

A clinical trial update for the COCO program (Colorectal Omics and ofCS Proteoglycans) focused on colorectal cancer screening and diagnostic pathways; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Colorectal Cancer
• Inflammatory Bowel Disease

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Colorectal Cancer, Colorectal Adenoma | Status: NOT_YET_RECRUITING